Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Zimmer Biomet price target lowered to $112 from $122 at BTIG
1h ago
JNJ
SYK
Premium
The Fly
Trump Weekly: Trump cuts China tariffs in deal on fentanyl, rare earths
5d ago
AA
MP
Premium
The Fly
FDA moves to accelerate biosimilar development, lower drug costs
6d ago
AZN
BMY
Premium
The Fly
Trump Trade: Texas sues Kenvue, J&J over Tylenol autism risk
7d ago
JNJ
SPY
Premium
The Fly
Johnson & Johnson to begin FcRn blockers study
7d ago
JNJ
Premium
The Fly
Citi says headlines could push consumers to alternatives to Kenvue’s Tylenol
8d ago
JNJ
KVUE
Premium
The Fly
Texas sues Kenvue, Johnson & Johnson over Tylenol autism risk
8d ago
JNJ
KVUE
Premium
The Fly
Clear Street sees ‘unmatched commercial promise’ for Protagonist’s icotrokinra
9d ago
JNJ
PTGX
Premium
The Fly
Johnson & Johnson announces psoriasis study shows preference for oral treatments
9d ago
JNJ
Premium
The Fly
Johnson & Johnson announces results from Phase 2b ANTHEM-UC study of icotrokinra
9d ago
JNJ
Premium
The Fly
Johnson & Johnson’s tremfya shows two-year durable remission in Crohn’s disease
9d ago
JNJ
Premium
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity
9d ago
AZN
JNJ
Premium
The Fly
Johnson & Johnson announces findings from Phase 2 DAHLIAS study
12d ago
JNJ
Premium
The Fly
Johnson & Johnson announces results from Phase 3 ICONIC-TOTAL study
12d ago
JNJ
Premium
The Fly
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
12d ago
JNJ
NBTX
Premium
The Fly
Trump Trade: Trump administration prepares new probe into pharma prices
14d ago
CI
AZN
Premium
The Fly
Johnson & Johnson downgraded to Hold from Buy at Freedom Capital
14d ago
JNJ
Premium
The Fly
Trump admin prepares new probe into U.S. pharma prices, FT says
14d ago
CI
AZN
Premium
The Fly
Bicara sinks after J&J reports head and neck cancer data
16d ago
JNJ
BCAX
Premium
The Fly
Johnson & Johnson announces new results from Phase 1b/2 OrigAMI-4 study
17d ago
JNJ
Premium
The Fly
Citi cautious on Kenvue after talc lawsuit filed in UK
20d ago
JNJ
KVUE
Premium
The Fly
J&J faces first UK lawsuits over talc cancer allegations, Reuters reports
20d ago
JNJ
KVUE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.